youtube_live
Q3 2026 earnings • in 1 day
See detailschevron_right
PCOR:NYSE
Procore Technologies Inc
$62.57
arrow_upward
+1.96%(+1.20) 1D
$62.57
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PCOR...
Open
$61.73
High
$64.51
Low
$61.22
Mkt. cap
9.51B
Avg. vol.
2.97M
Volume
2.97M
52-wk high
$82.32
52-wk low
$38.03
EPS
-$0.26
Beta
0.78
Shares outstanding
151.96M
No. of employees
4K
Open
$61.73
High
$64.51
Low
$61.22
Mkt. cap
9.51B
Avg. vol.
2.97M
Volume
2.97M
52-wk high
$82.32
52-wk low
$38.03
EPS
-$0.26
Beta
0.78
Shares outstanding
151.96M
No. of employees
4K
News stories
From web sources and news partners
GuruFocus
·
7 hours ago
PCOR Maintained by TD Cowen -- Price Target Raised to $70
Investing.com UK
·
11 hours ago
TD Cowen raises Procore stock price target to $70 on DroneDeploy
Yahoo Finance
·
14 hours ago
Procore Technologies (PCOR) to report earnings tomorrow: here is what to expect
Profile
Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling. Wikipedia
About Procore Technologies Inc
CEOAjei Gopal
Employees4.42K
Founded2002
HeadquartersCarpinteria, California, United States
SectorApplication software
Websiteprocore.com
Analyst ratings
Based on 12 analysts giving stock ratings to PCOR in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for PCOR in the last 3 months.
Highest
Current $62.57
$80.00 (+27.86%)
Average
$68.75 (+9.88%)
Lowest
$56.00 (-10.50%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Andrew Sherman TD Cowen | Buy | Reiterated | $70.00 | +11.9% | 11/02/2026 |
Saket Kalia Barclays | Buy | Maintained | $62.00 | -0.9% | 11/02/2026 |
John Difucci Guggenheim | Buy | Reiterated | $68.00 | +8.7% | 10/29/2026 |
Taylor McGinnis UBS | Buy | Reiterated | $80.00 | +27.9% | 10/26/2026 |
Aaron Kimson Citizens JMP | Buy | Maintained | $77.00 | +23.1% | 10/26/2026 |
Mason Marion Cantor Fitzgerald | Buy | Maintained | $70.00 | +11.9% | 10/21/2026 |
Matthew Martino Goldman Sachs | Buy | Reiterated | $70.00 | +11.9% | 10/21/2026 |
David Hynes Canaccord Genuity | Buy | Maintained | $72.00 | +15.1% | 10/22/2026 |
Adam Borg Stifel Nicolaus | Buy | Maintained | $63.00 | +0.7% | 10/20/2026 |
Billy Fitzsimmons Piper Sandler | Buy | Initiated | $68.00 | +8.7% | 09/28/2026 |
Clark Wright D.A. Davidson | Hold | Maintained | $56.00 | -10.5% | 09/28/2026 |
Unknown Analyst Cantor Fitzgerald | Buy | Initiated | $65.00 | +3.9% | 09/14/2026 |
Alexei Gogolev J.P. Morgan | Buy | Maintained | $69.00 | +10.3% | 08/04/2026 |
Joseph Vruwink Robert W. Baird | Buy | Maintained | $85.00 | +35.8% | 07/31/2026 |
Unknown Analyst Berenberg Bank | Buy | Maintained | $88.00 | +40.6% | 07/31/2026 |
Clarke Jeffries Piper Sandler | Buy | Reiterated | $68.00 | +8.7% | 07/31/2026 |
Dylan Becker William Blair | Buy | Maintained | - | - | 07/29/2026 |
Daniel Jester BMO Capital | Buy | Maintained | $56.00 | -10.5% | 07/24/2026 |
Nick Altmann BTIG | Buy | Maintained | $66.00 | +5.5% | 07/23/2026 |
Jason Celino KeyBanc | Buy | Maintained | - | - | 07/24/2026 |
Unknown Analyst Guggenheim | Buy | Initiated | $68.00 | +8.7% | 07/22/2026 |
Brent Thill Jefferies | Buy | Reiterated | $75.00 | +19.9% | 07/21/2026 |
Siti Panigrahi Mizuho Securities | Hold | Maintained | - | - | 05/06/2026 |
Kenneth Wong Oppenheimer | Hold | Maintained | - | - | 02/13/2026 |
Nay Soe Naing Berenberg Bank | Buy | Maintained | $88.00 | +40.6% | 02/13/2026 |
Next call in 35:27:32
Wed, Nov 4, 8:30 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.45
Revenue / Est. (USD)
- / 383.97M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 338.85M | 349.11M | 359.28M | 375.21M |
Cost of goods sold | 68.58M | 69.25M | 70.26M | 75.28M |
Cost of revenue | 68.58M | 69.25M | 70.26M | 75.28M |
Research and development expenses | 86.72M | 96.59M | 79.96M | 89.66M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 195.84M | 221.93M | 211.99M | 199.77M |
Operating expense | 284.23M | 320.23M | 294.43M | 291.13M |
Total operating expenses | 352.81M | 389.48M | 364.69M | 366.42M |
Operating income | -13.96M | -40.38M | -5.40M | 8.79M |
Other non operating income | 1.86M | 109.00K | -556.00K | 505.00K |
EBT including unusual items | -8.62M | -36.16M | -10.98M | 15.16M |
EBT excluding unusual items | -7.55M | -35.46M | -1.71M | 13.54M |
Income tax expense | 479.00K | 1.44M | -1.88M | -1.76M |
Effective tax rate | -5.56% | -3.98% | 17.13% | -11.60% |
Other operating expenses | 1.66M | 1.71M | 2.48M | 1.70M |
Net income | -9.10M | -37.60M | -9.10M | 16.92M |
Net profit margin | -2.69% | -10.77% | -2.53% | 4.51% |
Earnings per share | 0.42 | 0.37 | 0.34 | 0.47 |
Interest and investment income | 4.83M | 5.10M | 4.52M | 4.42M |
Interest expense | -276.00K | -294.00K | -268.00K | -179.00K |
Net interest expenses | 4.55M | 4.81M | 4.25M | 4.24M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 15.24M | -13.09M | 23.76M | 39.60M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events